PDB Short entry for 2MHS
HEADER    APOPTOSIS                               04-DEC-13   2MHS              
TITLE     NMR STRUCTURE OF HUMAN MCL-1                                          
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- 
COMPND   3 1;                                                                   
COMPND   4 CHAIN: A;                                                            
COMPND   5 FRAGMENT: UNP RESIDUES 171-327;                                      
COMPND   6 SYNONYM: BCL-2-LIKE PROTEIN 3, BCL2-L-3, BCL-2-RELATED PROTEIN       
COMPND   7 EAT/MCL1, MCL1/EAT;                                                  
COMPND   8 ENGINEERED: YES;                                                     
COMPND   9 MUTATION: YES                                                        
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: MCL1, BCL2L3;                                                  
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562;                                        
SOURCE   8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE   9 EXPRESSION_SYSTEM_PLASMID: PSR482-21.1                               
KEYWDS    MCL-1, BCL-2 FAMILY, BH DOMAIN, APOPTOSIS, CANCER DRUG, GFT NMR       
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    G.LIU,L.POPPE,K.AOKI,H.YAMANE,J.LEWIS,T.SZYPERSKI                     
REVDAT   2   14-JUN-23 2MHS    1       SEQADV                                   
REVDAT   1   14-MAY-14 2MHS    0                                                
JRNL        AUTH   G.LIU,L.POPPE,K.AOKI,H.YAMANE,J.LEWIS,T.SZYPERSKI            
JRNL        TITL   HIGH-QUALITY NMR STRUCTURE OF HUMAN ANTI-APOPTOTIC PROTEIN   
JRNL        TITL 2 DOMAIN MCL-1(171-327) FOR CANCER DRUG DESIGN.                
JRNL        REF    PLOS ONE                      V.   9 96521 2014              
JRNL        REFN                   ESSN 1932-6203                               
JRNL        PMID   24789074                                                     
JRNL        DOI    10.1371/JOURNAL.PONE.0096521                                 
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : VNMR, CNS                                            
REMARK   3   AUTHORS     : VARIAN (VNMR), BRUNGER, ADAMS, CLORE, GROS, NILGES   
REMARK   3                 AND READ (CNS)                                       
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2MHS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-13.                  
REMARK 100 THE DEPOSITION ID IS D_1000103631.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298                                
REMARK 210  PH                             : 7.4                                
REMARK 210  IONIC STRENGTH                 : 0.3                                
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 0.7 MM [U-100% 13C; U-100% 15N]    
REMARK 210                                   MCL-1, 95% H2O/5% D2O; 0.7 MM [U-  
REMARK 210                                   5% 13C; U-100% 15N] MCL-1, 95%     
REMARK 210                                   H2O/5% D2O                         
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 3D 15N/13CALIPHATIC/13CAROMATIC    
REMARK 210                                   -RESOLVED NOESY; GFT(4,3)D         
REMARK 210                                   HNNCABCA; GFT(4,3)DCABCACONHN;     
REMARK 210                                   GFT(4,3)D HABCABCONHN; GFT(4,3)D   
REMARK 210                                   HNNCO; GFT (4,3)D HCCH; 2D 1H-     
REMARK 210                                   13C HSQC; 2D 1H-15N HSQC; 2D 1H-   
REMARK 210                                   13C HSQC AROMATIC                  
REMARK 210  SPECTROMETER FIELD STRENGTH    : 750 MHZ; 600 MHZ                   
REMARK 210  SPECTROMETER MODEL             : INOVA                              
REMARK 210  SPECTROMETER MANUFACTURER      : VARIAN                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NMRPIPE, XEASY, AUTOASSIGN,        
REMARK 210                                   AUTOSTRUCTURE, CYANA, CNS,         
REMARK 210                                   SPSCAN, PSVS                       
REMARK 210   METHOD USED                   : DISTANCE GEOMETRY, MOLECULAR       
REMARK 210                                   DYNAMICS, SIMULATED ANNEALING,     
REMARK 210                                   TORSION ANGLE DYNAMICS             
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 100                                
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : TARGET FUNCTION                    
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS                                             
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 ARG A  32      -80.43     60.98                                   
REMARK 500  1 LEU A  66      -76.05    -82.20                                   
REMARK 500  1 ASP A  67       91.89     47.21                                   
REMARK 500  1 VAL A  89     -177.54    -62.85                                   
REMARK 500  1 THR A  90      -78.99    -87.00                                   
REMARK 500  1 ASN A  91       89.58     45.41                                   
REMARK 500  1 GLN A 114       45.55    -84.82                                   
REMARK 500  1 HIS A 151       72.48     56.65                                   
REMARK 500  1 VAL A 152      -68.52   -103.16                                   
REMARK 500  1 GLU A 156      -62.64   -105.58                                   
REMARK 500  1 HIS A 160       57.73   -154.16                                   
REMARK 500  2 ALA A  24     -156.62   -140.24                                   
REMARK 500  2 PRO A  29      -77.20    -58.23                                   
REMARK 500  2 MET A  30      -30.75    174.63                                   
REMARK 500  2 LEU A  66      -69.57    -99.94                                   
REMARK 500  2 ASP A  67      -48.63     71.70                                   
REMARK 500  2 ILE A  68       98.24     62.97                                   
REMARK 500  2 THR A  90       20.57    -77.38                                   
REMARK 500  2 ASN A  91       81.00    -68.57                                   
REMARK 500  2 GLN A 114       38.86    -92.74                                   
REMARK 500  2 ARG A 141       80.83     59.84                                   
REMARK 500  2 HIS A 159      -61.70     69.86                                   
REMARK 500  2 HIS A 160      103.86    -44.42                                   
REMARK 500  3 ALA A  24     -159.89   -112.06                                   
REMARK 500  3 ARG A  32      -76.85   -104.87                                   
REMARK 500  3 LEU A  66      -73.66   -118.90                                   
REMARK 500  3 ASP A  67      -43.86     70.45                                   
REMARK 500  3 ILE A  68       90.27     62.83                                   
REMARK 500  3 THR A  90      -62.11     63.58                                   
REMARK 500  3 TRP A  92       11.32    -69.24                                   
REMARK 500  3 ARG A 141       60.16     61.61                                   
REMARK 500  3 HIS A 159      107.64    -42.70                                   
REMARK 500  4 THR A  27       19.96   -148.67                                   
REMARK 500  4 LEU A  66      -76.18   -117.18                                   
REMARK 500  4 ASP A  67      -40.72     71.12                                   
REMARK 500  4 ILE A  68       94.25     60.42                                   
REMARK 500  4 PHE A  85       32.76    -88.57                                   
REMARK 500  4 GLN A 114       36.99    -99.61                                   
REMARK 500  4 ARG A 141       89.71     62.29                                   
REMARK 500  4 GLU A 156      -45.50   -140.31                                   
REMARK 500  5 MET A  30      -83.43   -117.14                                   
REMARK 500  5 ASP A  67       97.71     54.37                                   
REMARK 500  5 THR A  90       86.10    -67.66                                   
REMARK 500  5 GLN A 114       40.84    -91.95                                   
REMARK 500  5 ARG A 141       72.17     51.49                                   
REMARK 500  5 HIS A 151       74.83     65.75                                   
REMARK 500  5 ASP A 154     -164.68   -102.62                                   
REMARK 500  5 GLU A 156      -71.58   -115.99                                   
REMARK 500  5 HIS A 163       12.44     58.00                                   
REMARK 500  6 THR A  27       48.55   -143.27                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS     181 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 19654   RELATED DB: BMRB                                 
DBREF  2MHS A    2   158  UNP    Q07820   MCL1_HUMAN     171    327             
SEQADV 2MHS MET A    1  UNP  Q07820              INITIATING METHIONINE          
SEQADV 2MHS SER A  117  UNP  Q07820    CYS   286 ENGINEERED MUTATION            
SEQADV 2MHS HIS A  159  UNP  Q07820              EXPRESSION TAG                 
SEQADV 2MHS HIS A  160  UNP  Q07820              EXPRESSION TAG                 
SEQADV 2MHS HIS A  161  UNP  Q07820              EXPRESSION TAG                 
SEQADV 2MHS HIS A  162  UNP  Q07820              EXPRESSION TAG                 
SEQADV 2MHS HIS A  163  UNP  Q07820              EXPRESSION TAG                 
SEQADV 2MHS HIS A  164  UNP  Q07820              EXPRESSION TAG                 
SEQRES   1 A  164  MET GLU ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE          
SEQRES   2 A  164  SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP          
SEQRES   3 A  164  THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS          
SEQRES   4 A  164  ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN          
SEQRES   5 A  164  ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS          
SEQRES   6 A  164  LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER          
SEQRES   7 A  164  ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN          
SEQRES   8 A  164  TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE          
SEQRES   9 A  164  VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER SER          
SEQRES  10 A  164  ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL          
SEQRES  11 A  164  ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP          
SEQRES  12 A  164  ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU          
SEQRES  13 A  164  GLY GLY HIS HIS HIS HIS HIS HIS                              
HELIX    1   1 ASP A    3  GLY A   23  1                                  21    
HELIX    2   2 SER A   33  ASP A   67  1                                  35    
HELIX    3   3 ASN A   70  VAL A   84  1                                  15    
HELIX    4   4 ASN A   91  ILE A  112  1                                  22    
HELIX    5   5 GLN A  114  LYS A  133  1                                  20    
HELIX    6   6 LYS A  133  GLN A  140  1                                   8    
HELIX    7   7 ARG A  141  PHE A  150  1                                  10    
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000